Gregory Renza
Stock Analyst at Truist Financial
(4.82)
# 454
Out of 4,476 analysts
792
Total ratings
53.1%
Success rate
18.5%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABVX ABIVAX Société Anonyme | Maintained: Buy | $135 → $155 | $144.65 | +7.16% | 12 | Jul 2, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | n/a | $297.65 | - | 15 | Jul 1, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | $35 → $38 | $19.40 | +95.88% | 34 | Jun 30, 2026 | |
| ZYME Zymeworks | Maintained: Buy | n/a | $26.31 | - | 3 | Jun 30, 2026 | |
| GMAB Genmab | Maintained: Buy | n/a | $28.52 | - | 3 | Jun 30, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $210 | $189.24 | +10.97% | 4 | Jun 30, 2026 | |
| EXEL Exelixis | Initiated Coverage: Hold | $40 → $54 | $55.85 | -3.31% | 32 | Jun 25, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | n/a | $243.47 | - | 39 | Jun 18, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | n/a | $131.27 | - | 14 | Jun 16, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Buy | $36 | $37.59 | -4.23% | 41 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.70 | - | 25 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $124 | $123.73 | +0.22% | 8 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $23.97 | +33.50% | 26 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $37.65 | - | 31 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $4 | $3.84 | +4.17% | 16 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.52 | - | 35 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $83 | $37.44 | +121.69% | 1 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $70.36 | - | 19 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $778 | $654.27 | +18.91% | 11 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.63 | - | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $15.00 | +93.33% | 31 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $23.46 | +61.98% | 1 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $325 → $327 | $374.15 | -12.60% | 37 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $7 | $4.35 | +60.92% | 8 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $22 | $18.19 | +22.81% | 3 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $25.97 | n/a | 57 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.19 | n/a | 24 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $1.22 | n/a | 36 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $4.50 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $6.14 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $46 | $0.4283 | n/a | 8 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 | $25.39 | n/a | 31 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $0.5925 | n/a | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $13 | $8.75 | n/a | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38 | $52.51 | n/a | 26 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32.66 → $25.56 | $2.40 | n/a | 24 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2,160 → $180 | $18.84 | n/a | 11 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $80 | $0.741 | n/a | 18 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 → $15 | $0.0499 | n/a | 14 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $348 | $216.12 | n/a | 1 | Sep 8, 2015 |
ABIVAX Société Anonyme
Jul 2, 2026
Maintained: Buy
Price Target: $135 → $155
Current: $144.65
Upside: +7.16%
BeOne Medicines AG
Jul 1, 2026
Maintained: Buy
Price Target: n/a
Current: $297.65
Upside: -
Viridian Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $35 → $38
Current: $19.40
Upside: +95.88%
Zymeworks
Jun 30, 2026
Maintained: Buy
Price Target: n/a
Current: $26.31
Upside: -
Genmab
Jun 30, 2026
Maintained: Buy
Price Target: n/a
Current: $28.52
Upside: -
Revolution Medicines
Jun 30, 2026
Reiterated: Buy
Price Target: $210
Current: $189.24
Upside: +10.97%
Exelixis
Jun 25, 2026
Initiated Coverage: Hold
Price Target: $40 → $54
Current: $55.85
Upside: -3.31%
Jazz Pharmaceuticals
Jun 18, 2026
Maintained: Buy
Price Target: n/a
Current: $243.47
Upside: -
Gilead Sciences
Jun 16, 2026
Maintained: Buy
Price Target: n/a
Current: $131.27
Upside: -
Agios Pharmaceuticals
Jun 15, 2026
Maintained: Buy
Price Target: $36
Current: $37.59
Upside: -4.23%
Jun 10, 2026
Maintained: Buy
Price Target: n/a
Current: $5.70
Upside: -
Jun 10, 2026
Downgraded: Hold
Price Target: $124
Current: $123.73
Upside: +0.22%
Jun 9, 2026
Reiterated: Buy
Price Target: $32
Current: $23.97
Upside: +33.50%
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $37.65
Upside: -
Jun 2, 2026
Downgraded: Hold
Price Target: $17 → $4
Current: $3.84
Upside: +4.17%
Jun 1, 2026
Maintained: Buy
Price Target: n/a
Current: $4.52
Upside: -
May 27, 2026
Initiated Coverage: Buy
Price Target: $83
Current: $37.44
Upside: +121.69%
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $70.36
Upside: -
May 18, 2026
Maintained: Buy
Price Target: $778
Current: $654.27
Upside: +18.91%
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $3.63
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: $29
Current: $15.00
Upside: +93.33%
May 4, 2026
Reiterated: Buy
Price Target: $38
Current: $23.46
Upside: +61.98%
May 1, 2026
Maintained: Hold
Price Target: $325 → $327
Current: $374.15
Upside: -12.60%
May 1, 2026
Maintained: Hold
Price Target: $8 → $7
Current: $4.35
Upside: +60.92%
Apr 24, 2026
Maintained: Buy
Price Target: $51 → $22
Current: $18.19
Upside: +22.81%
May 19, 2025
Reiterated: Buy
Price Target: $26
Current: $25.97
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: $8
Current: $1.19
Upside: n/a
May 13, 2025
Maintained: Hold
Price Target: $5
Current: $1.22
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $16
Current: $4.50
Upside: n/a
May 13, 2025
Maintained: Hold
Price Target: $20
Current: $6.14
Upside: n/a
May 12, 2025
Maintained: Buy
Price Target: $48 → $46
Current: $0.4283
Upside: n/a
May 8, 2025
Maintained: Hold
Price Target: $26
Current: $25.39
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $16
Current: $0.5925
Upside: n/a
May 6, 2025
Maintained: Buy
Price Target: $12 → $13
Current: $8.75
Upside: n/a
May 6, 2025
Maintained: Hold
Price Target: $38
Current: $52.51
Upside: n/a
Nov 10, 2023
Maintained: Buy
Price Target: $32.66 → $25.56
Current: $2.40
Upside: n/a
Jun 26, 2023
Downgraded: Hold
Price Target: $2,160 → $180
Current: $18.84
Upside: n/a
Mar 16, 2022
Maintained: Hold
Price Target: $5 → $80
Current: $0.741
Upside: n/a
Nov 12, 2021
Maintained: Hold
Price Target: $1 → $15
Current: $0.0499
Upside: n/a
Sep 8, 2015
Rated: Buy
Price Target: $348
Current: $216.12
Upside: n/a